Click here to go to the previous page
CLINICAL - All Patients with Hypertension Should Have Measurement of Renin To Allow Identification of Primary Aldosteronism
Program Code:
D01-0
Date:
Wednesday, June 10, 2009
Time:
2:45 PM to 3:30 PM
EST
SPEAKER
(S):
RJ Auchus, MD, PhD, Univ of Texas SW Med Ctr.
Disclosure: Nothing to disclose
NM Kaplan, MD, Univ of Texas SW Med Ctr.
Disclosure: Nothing to disclose
MJ Brown,
MD, FRCP,
Univ of Cambridge.
Disclosure: Nothing to disclose
|
MORRIS BROWN MA, MSc, MD, FRCP, FAHA, FMedSci
University of Cambridge, UK
Morris Brown is Professor of Clinical Pharmacology at the University of Cambridge and Honorary Consultant Physician at Addenbrooke’s Hospital, Cambridge. He was President of the British Hypertension Society 2005-2007, co-author of NICE/BHS guideline in 2006, and now chairs the BHS Research Working Party. He is leading a British Heart Foundation funded programme of three trials investigating the role of renin measurement in the routine management of hypertension. In 2008 he became Director of one of the Wellcome Trust-funded centres for Translational Medicine and Therapeutics in Cambridge, UK.
His research interest is mechanisms of low-renin hypertension. He was awarded the Lilly Gold Medal of the British Pharmacological Society (2002), and the Walter Somerville Medal of the British Cardiac Society (2006). His introduction of the AB/CD rule, and innovations in management of phaeochromocytoma and Conn’s syndrome, led to the UK Hospital Doctors’ Award in 2003.
|